Background Drug-eluting stents (DES) have been shown to significantly reduce clinical events and angiographic
restenosis in the treatment of coronary artery disease (CAD). This study was conducted to assess the long-term efficacy
and safety of the polymer-based sirolimus-eluting cobalt-chromium Firebird 2™ stents in the treatment of patients with CAD. ...